• EMA: A warning about unusual blood clots with low blood platelets should be added to the product information for Johnson & Johnson's (JNJ) COVID-19 Vaccine Janssen

Notícias do Mercado

20 abril 2021

EMA: A warning about unusual blood clots with low blood platelets should be added to the product information for Johnson & Johnson's (JNJ) COVID-19 Vaccine Janssen

  • These events should be listed as very rare side effects of the vaccine
  • Overall benefits of COVID-19 Vaccine Janssen in preventing COVID-19 outweigh the risks of side effects

EMA's full release 

CAD: Risk skewed for a dovish taper from the BoC and tactical USD/CAD upside - Citi
EUR: Not expecting any change to monetary policy stance nor more clarity on policy framework - Barclays
O foco de mercado
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer
Abrir Conta Demo e Página Pessoal
Compreendo e aceito a Política de Privacidade e concordo que os meus dados sejam processados pela TeleTrade e usados para os seguintes efeitos:
Área pessoal
Área pessoal
support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.

Política de privacidade

© 2000-2023. Todos os direitos são reservados.